Silica Skin Support DKS Special Order
- Manufacturer
- Uriel Pharmacy Inc.
- Effective date
- 2018-05-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:59:03
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Directions: FOR ORAL USE ONLY.
DOSAGE & ADMINISTRATION SECTION
Take regularly before meals with a small amount of water. Ages 12 and older: 1 teaspoon. Ages 2-11: 1/2 teaspoon. Under age 2: Consult a doctor.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients: Stannum met. (Metallic tin) 3X, Cinis equiseti (Ash of horsetail herb) 5X, Cinis quercus (Decoction of oak bark ash) 9X, Cor (Bovine heart) 9X, Hepar (Bovine liver) 9X, Pancreas (Bovine pancreas) 9X, Pulmo (Bovine lung) 9X, Quercus (Oak) 9X, Renes (Bovine kidneys) 9X, Mesenchyme (Porcine embryonic connective tissue) 11X
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Lactose, Bee pollen, Diatomaceous earth, Anise oil
OTC - PURPOSE SECTION
Uses: To promote skin elasticity and strengthen hair and nails.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
KEEP OUT OF REACH OF CHILDREN.
WARNINGS SECTION
Warnings: Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated. Do not use if allergic to any ingredient. Contains lactose. Consult a doctor before use for serious conditions or if conditions worsen or persist. If pregnant or nursing, consult a doctor before use. Do not use if safety seal is broken or missing.
OTC - QUESTIONS SECTION
Questions? Call 866.642.2858 Made with care by Uriel, East Troy, WI 53120
www.urielpharmacy.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANTIMONY | ACTIVE INGREDIENT | 9IT35J3UV3 | 1 | |
| BEEF HEART | ACTIVE INGREDIENT | P47W069U38 | 1 | |
| BOS TAURUS CARTILAGE | ACTIVE INGREDIENT | UE77B10IIY | 1 | |
| EQUISETUM ARVENSE TOP | ACTIVE INGREDIENT | 1DP6Y6B65Z | 1 | |
| MAMMAL LIVER | ACTIVE INGREDIENT | D0846624BI | 1 | |
| PORK KIDNEY | ACTIVE INGREDIENT | X7BCI5P86H | 1 | |
| QUERCUS ROBUR WHOLE | ACTIVE INGREDIENT | R7QMG0BT2W | 1 | |
| SUS SCROFA LUNG | ACTIVE INGREDIENT | 7GL3G1COB3 | 1 | |
| SUS SCROFA PANCREAS | ACTIVE INGREDIENT | 9Y3J3362RY | 1 | |
| ANTIMONY | ACTIVE MOIETY | 9IT35J3UV3 | 1 | |
| BEEF HEART | ACTIVE MOIETY | P47W069U38 | 1 | |
| BOS TAURUS CARTILAGE | ACTIVE MOIETY | UE77B10IIY | 1 | |
| EQUISETUM ARVENSE TOP | ACTIVE MOIETY | 1DP6Y6B65Z | 1 | |
| MAMMAL LIVER | ACTIVE MOIETY | D0846624BI | 1 | |
| PORK KIDNEY | ACTIVE MOIETY | X7BCI5P86H | 1 | |
| QUERCUS ROBUR WHOLE | ACTIVE MOIETY | R7QMG0BT2W | 1 | |
| SUS SCROFA LUNG | ACTIVE MOIETY | 7GL3G1COB3 | 1 | |
| SUS SCROFA PANCREAS | ACTIVE MOIETY | 9Y3J3362RY | 1 | |
| ANISE OIL | INACTIVE INGREDIENT | 6Y89129C8H | 1 | |
| BEE POLLEN | INACTIVE INGREDIENT | 3729L8MA2C | 1 | |
| DIATOMACEOUS EARTH | INACTIVE INGREDIENT | 2RF6EJ0M85 | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 |
Products#
Every source-derived product name is available through these pages.
- Silica Skin Support DKS Special Order
- LACTOSE
- BEE POLLEN
- DIATOMACEOUS EARTH
- ANISE OIL
- EQUISETUM ARVENSE TOP
- ANTIMONY
- QUERCUS ROBUR WHOLE
- BEEF HEART
- PORK KIDNEY
- MAMMAL LIVER
- BOS TAURUS CARTILAGE
- SUS SCROFA PANCREAS
- SUS SCROFA LUNG
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 48951-8300 | 48951-8300-4 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE | J2B2A4N98G | IACT |
| BEE POLLEN | 3729L8MA2C | IACT |
| DIATOMACEOUS EARTH | 2RF6EJ0M85 | IACT |
| ANISE OIL | 6Y89129C8H | IACT |
| EQUISETUM ARVENSE TOP | 1DP6Y6B65Z | ACTIB |
| ANTIMONY | 9IT35J3UV3 | ACTIB |
| QUERCUS ROBUR WHOLE | R7QMG0BT2W | ACTIB |
| BEEF HEART | P47W069U38 | ACTIB |
| PORK KIDNEY | X7BCI5P86H | ACTIB |
| MAMMAL LIVER | D0846624BI | ACTIB |
| BOS TAURUS CARTILAGE | UE77B10IIY | ACTIB |
| SUS SCROFA PANCREAS | 9Y3J3362RY | ACTIB |
| SUS SCROFA LUNG | 7GL3G1COB3 | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | TABLET, EXTENDED RELEASE / ORAL | 5 mg | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | PASTILLE / ORAL | 16 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | DROPS / ORAL | 0.4 mg/1ml | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | SOLUTION / ORAL | 1.4 mg | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | TABLET, COATED / ORAL | 7.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | ELIXIR / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | POWDER, DENTIFRICE / DENTAL | NA | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | ELIXIR / ORAL | 0.15 ml/5ml | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | CAPSULE / ORAL | 3.4 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | TABLET / ORAL | 88 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | SOAP / TOPICAL | 0.27 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / RECTAL | 8 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | CONCENTRATE / ORAL | NA | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | PASTE, DENTIFRICE / DENTAL | NA | ||
| DIATOMACEOUS EARTH | DIATOMACEOUS EARTH | 2RF6EJ0M85 | SYRUP / ORAL | NA | ||
| ANISE OIL | ANISE OIL | 6Y89129C8H | SUSPENSION / ORAL | 1 ml/5ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c58572a8-5a4f-eb1b-e053-2995a90ae50e | 02467e89-c34e-4acf-bc93-2b02c4a86195 | 2021-06-24 | Warnings | 02467e89-c34e-4acf-bc93-2b02c4a86195 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
